As a strategy to increase its chances of FDA approval for the next-generation aminoglycoside anti-infective, plazomicin, Achaogen Inc. changed course after Phase II trials and narrowed the indicat
Mergers & Acquisitions AcryMed Inc. & I-Flow Corp. Pain management and infusion therapy company I-Flow has signed a letter of intent to buy closely held AcryMed (infection and wound care dressings